RC2NB is pleased to share significant progress in the MultiSCRIPT Trial. Despite the summer break, our recruitment efforts have remained strong, and we have successfully enrolled 373 participants, an impressive 40% of our target sample size.
We are also delighted to welcome two centers that recently joined the MultiSCRIPT initiative: Inselspital and Zurich University Hospital. Their involvement marks a valuable expansion of our collaborative efforts.
The ongoing success of the MultiSCRIPT Trial highlights the effectiveness of integrating research seamlessly into the routine care provided by SMSC. This approach streamlines the research process and generates high-quality evidence that directly informs clinical decision-making.
This achievement would not be possible without the unwavering dedication and hard work of our SMSC physicians, study coordinators, and nurses and most importantly the commitment of our participants.
To stay updated on our progress and learn more about how MultiSCRIPT is shaping the future of care, visit our website: https://multiscript.rc2nb.ch. Join us on this journey of discovery and innovation!
Thank you for being an essential part of this journey.
